Log in to your Inderes Free account to see all free content on this page.
Xvivo Perfusion
515 SEK -0.58%2 investors are following this company
Xvivo Perfusion is a medical technology company. The company provides solutions for lung transplantation. Examples of products that the company delivers include needles, organ storage, and cooling solutions. The products are resold to clinics and research institutes around the global market, with the largest business presence in the Nordics and Europe. The company was established via a spin-off from Vitrolife in 2012 and is headquartered in Gothenburg.
Revenue
-
EBIT %
-
P/E
167.75
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
XVIVO
Daily low / high price
511 / 523
SEK
Market cap
16.22B SEK
Turnover
9.12M SEK
Volume
18K
Latest videos
Financial calendar
Interim report
24.10.2024
Annual report
28.01.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Bure Equity | 14.3 % | 14.3 % |
Fjärde AP-fonden | 9.0 % | 9.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
XVIVO, Audiocast with teleconference, Q2'24
Interim report January – June 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio